Dermata Therapeutics (DRMA) vs Propanc Biopharma (PPCB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Dermata Therapeutics is the larger company by market cap ($5.3 million vs $4.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | DRMA | PPCB |
|---|---|---|
| Share price | $1.07 | $0.471 |
| Market cap | $5.30M | $4.63M |
| 1-day change | -4.46% | -5.55% |
| EPS (TTM) | $-4.39 | $-17.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.66 | $48.75 |
| 52-week low | $0.951 | $0.46 |
| Distance from 52-week high | -77.04% | -99.03% |
| Analyst consensus | none | — |
| Avg. price target upside | +273.83% | — |
| Average volume | 706.43K | 1.79M |
| Shares outstanding | 4.96M | 9.83M |
| Employees | 9 | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Dermata Therapeutics
DRMA stock →Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States.
Healthcare · Biotechnology · 9 employees
About Propanc Biopharma
PPCB stock →Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies.
Healthcare · Biotechnology · 2 employees
DRMA vs PPCB FAQ
Which is bigger, Dermata Therapeutics or Propanc Biopharma?
Dermata Therapeutics (DRMA) is larger, with a market capitalization of $5.30M compared with $4.63M for Propanc Biopharma (PPCB).
Are Dermata Therapeutics and Propanc Biopharma in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.